Albuterol in Underweight, Fluctuating Patients with Parkinson's disease: A Pilot Study
$600 Compensation
for volunteers with Parkinson's disease who- HAVE RECENT WEIGHT LOSS or THIN STATURE and
- DECREASED EFFECTIVENESS OF CARBIDOPA/LEVODOPA (SINEMETÒ )
- No need to be a veteran to participate
Funded by the Biomedical Research Foundation, affilliated with the CAVHS (Central Arkansas Veterans Healthcare System ).
This 14-week study will test if albuterol makes the Parkinson medication called carbidopa/levodopa (SinemetÒ ) work longer and helps to gain muscle mass and strength. Albuterol (VentolinÒ, ProventilÒ) has been on the market for the treatment of asthma for many years.
Where? At GCRC (General Clinical Research Center), a NIH (National Institutes of Health) funded modern facility for human research, located at the John L. McClellan Memorial Veterans Hospital in Little Rock.
Principal Investigators: Dr. Ergun Y. Uc, a staff physician with the Dept. of Neurology at UAMS and CAVHS, had specialized training in treatment of Parkinson’s Disease. He is the only member of the PSG (Parkinson Study Group) in Arkansas. Dr. William J. Evans, an internationally recognized expert on muscle metabolism and exercise physiology, is a scientist with the Geriatric Research Education and Clinical Center at the CAVHS and UAMS.
Compensation: Eligible volunteers will receive limited physical exams, laboratory tests, and albuterol at no cost. Participants will be paid $600 for completing this study. The payment will be pro-rated should either the investigators terminate the study or the volunteer withdraws his/her participation prior to the completion of the study.
Contact Dr. Ergun Y. Uc by phone at 501-686-5135 or fax at 501-686-8689 or e-mail at ucerguny@exchange.uams.edu or write to Dept. of Neurology at UAMS, 4301 W. Markham Slot 500, Little Rock AR 72205. Visit www.uams.edu/movementdisorders